Compare BioNano Genomics Inc (BNGO) vs iShares Semiconductor ETF (SOXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs iShares Semiconductor ETF — how do they compare? BioNano Genomics Inc trades at $1.19 (market cap $13.66M), while iShares Semiconductor ETF trades at $552.15. The key difference: iShares Semiconductor ETF is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | SOXX | |
|---|---|---|
Market Cap | $13.66M | — |
Sector | Health | Sector/Thematic |
52-Week High | $4.92 | $655.01 |
52-Week Low | $1.06 | $241.68 |
Enterprise Value | $16.26M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.19, up 2.59% today, with bullish technical signals from moving averages. The company shows improving financials with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable. Recent earnings have consistently beaten expectations, and analyst sentiment is positive with 57% buy ratings. Key developments include debt retirement and scientific publications highlighting optical genome mapping adoption.
The outlook is cautiously optimistic given improving fundamentals and positive analyst coverage, but significant risks remain due to persistent losses and negative cash flow. Investment opportunity lies in the company's technology adoption growth, while primary risks include profitability challenges and competitive pressures in the genomics space.
SOXX, the iShares Semiconductor ETF, trades at $550.61, up 3.88% in the last session, with a bullish technical signal driven by moving averages. Recent news highlights sector volatility, including a 21% plunge in July due to headwinds like short-seller commentary and competitive pressures, though major cloud company growth supports AI spending optimism. The ETF's concentration in 30 semiconductor stocks contrasts with broader tech diversification options.
Outlook hinges on semiconductor demand from AI and data centers, with potential from U.S. policy support, but risks include tariff impacts, high valuation concerns, and sector rotation. Investors face trade-offs between SOXX's focused exposure and broader, lower-fee alternatives amid ongoing market efficiency and inflow trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About iShares Semiconductor ETF
SOXX provides investors with exposure to U.S. companies that design, manufacture, and distribute semiconductors. It tracks the ICE Semiconductor Index, offering a targeted investment in the technology sector's foundational components, including firms that produce chips, related equipment, and services. SOXX is a key vehicle for investors seeking to capitalize on trends in artificial intelligence, 5G, and other technologies that rely heavily on advanced semiconductor technology.
Read more on SOXX →
